Disturbed regulatory T cell homeostasis in multiple sclerosis
- PMID: 20159585
- DOI: 10.1016/j.molmed.2009.12.003
Disturbed regulatory T cell homeostasis in multiple sclerosis
Abstract
The pathological features of multiple sclerosis (MS), a chronic inflammatory disorder of the central nervous system, support an autoimmune etiology. Strong evidence has been provided for a potential functional defect of CD4(+)CD25(+)FOXP3(+) regulatory T cells (Tregs) in patients with relapsing-remitting MS. More recently, alterations in homeostatic parameters related to the development and function of naive and memory-like Tregs were discovered in MS patients. In this review, we evaluate the evidence for disturbed Treg homeostasis in MS and discuss the role of potential compensatory mechanisms in the chronic disease phase. Better insights into the processes underlying the compromised immune regulation in MS patients will be important to understand the potential of Treg-based therapies.
Similar articles
-
Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.J Neurosci Res. 2006 Jun;83(8):1432-46. doi: 10.1002/jnr.20852. J Neurosci Res. 2006. PMID: 16583400
-
Dysfunction of IL-10-producing type 1 regulatory T cells and CD4(+)CD25(+) regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys.Int Immunopharmacol. 2009 May;9(5):599-608. doi: 10.1016/j.intimp.2009.01.034. Epub 2009 Feb 10. Int Immunopharmacol. 2009. PMID: 19539557
-
Natural naive CD4+CD25+CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression.J Immunol. 2008 May 1;180(9):6411-20. doi: 10.4049/jimmunol.180.9.6411. J Immunol. 2008. PMID: 18424765
-
The role of regulatory T cells in multiple sclerosis.Nat Clin Pract Neurol. 2008 Jul;4(7):384-98. doi: 10.1038/ncpneuro0832. Epub 2008 Jun 24. Nat Clin Pract Neurol. 2008. PMID: 18578001 Review.
-
The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology?Int Rev Neurobiol. 2007;79:73-97. doi: 10.1016/S0074-7742(07)79004-9. Int Rev Neurobiol. 2007. PMID: 17531838 Review.
Cited by
-
Histamine H4 receptor optimizes T regulatory cell frequency and facilitates anti-inflammatory responses within the central nervous system.J Immunol. 2012 Jan 15;188(2):541-7. doi: 10.4049/jimmunol.1101498. Epub 2011 Dec 5. J Immunol. 2012. PMID: 22147765 Free PMC article.
-
Modulating effects of leflunomide on the balance of Th17/Treg cells in collageninduced arthritis DBA/1 mice.Cent Eur J Immunol. 2014;39(2):152-8. doi: 10.5114/ceji.2014.43714. Epub 2014 Jun 27. Cent Eur J Immunol. 2014. PMID: 26155116 Free PMC article.
-
Regulatory B and T lymphocytes in multiple sclerosis: friends or foes?Auto Immun Highlights. 2018 Nov 10;9(1):9. doi: 10.1007/s13317-018-0109-x. Auto Immun Highlights. 2018. PMID: 30415321 Free PMC article. Review.
-
The Involvement of Calpain in CD4+ T Helper Cell Bias in Multple Sclerosis.J Clin Cell Immunol. 2013 Jun 14;4(4):1000153. doi: 10.4172/2155-9899.1000153. J Clin Cell Immunol. 2013. PMID: 24707444 Free PMC article.
-
Compositional changes of B and T cell subtypes during fingolimod treatment in multiple sclerosis patients: a 12-month follow-up study.PLoS One. 2014 Oct 31;9(10):e111115. doi: 10.1371/journal.pone.0111115. eCollection 2014. PLoS One. 2014. PMID: 25360562 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
